NanoSurface Biomedical Launches New Drug Screening Platform with Structurally Matured Human Heart Tissues Derived from Stem Cells
SEATTLE–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/biotech?src=hash” target=”_blank”gt;#biotechlt;/agt;–NanoSurface Biomedical, a leading provider of biomimetic cell-based assay products and services, announced today the launch of…